EMpagliflozin iMpurity 14
|
|
|
- CAS-Nr.
- 2137418-13-2
- Englisch Name:
- EMpagliflozin iMpurity 14
- Synonyma:
- Empagliflozin-13;Empagliflozin Impurity 64;D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[hydroxy[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-, (1S)-;(2S,3R,4R,5S,6R)-2-(4-chloro-3-(hydroxy(4-(((S)-tetrahydrofuran-
3-yl)oxy)phenyl)methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-
pyran-3,4,5-triol;Empagliflozin impurity 16/(2S,3R,4R,5S,6R)-2-(4-chloro-3-(hydroxy(4-(((S)-tetrahydrofuran- 3-yl)oxy)phenyl)methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H- pyran-3,4,5-triol
- CBNumber:
- CB12728633
- Summenformel:
- C23H27ClO8
- Molgewicht:
- 466.91
- MOL-Datei:
- 2137418-13-2.mol
|
EMpagliflozin iMpurity 14 Eigenschaften
- Siedepunkt:
- 706.3±60.0 °C(Predicted)
- Dichte
- 1.456±0.06 g/cm3(Predicted)
- pka
- 13.18±0.20(Predicted)
Sicherheit
EMpagliflozin iMpurity 14 Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
Hydroxy Empagliflozin is an impurity of Empagliflozin (E521510), a novel, potent and selective SGLT-2 inhibitor. It improves glycaemic control syndrome in diabetic rats.
EMpagliflozin iMpurity 14 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
EMpagliflozin iMpurity 14 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 40)Lieferanten
- (2S,3R,4R,5S,6R)-2-(4-chloro-3-(hydroxy(4-(((S)-tetrahydrofuran-
3-yl)oxy)phenyl)methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-
pyran-3,4,5-triol
- Empagliflozin Impurity 64
- Empagliflozin-13
- Empagliflozin impurity 16/(2S,3R,4R,5S,6R)-2-(4-chloro-3-(hydroxy(4-(((S)-tetrahydrofuran- 3-yl)oxy)phenyl)methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H- pyran-3,4,5-triol
- D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[hydroxy[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-, (1S)-
- 2137418-13-2
